サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：治療薬モニタリング市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年
市場調査レポート
商品コード
1309221

治療薬モニタリング市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年

Therapeutic Drug Monitoring Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Product, By Technology, By Class of Drug, By End User, By Region, and Competition
出版日: | 発行: TechSci Research | ページ情報: 英文 113 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

治療薬モニタリング市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年
出版日: 2023年07月01日
発行: TechSci Research
ページ情報: 英文 113 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の治療薬モニタリング市場は、予測期間中に目覚ましい成長を遂げると予測されています。

世界のヘルスケア産業の拡大が治療薬モニタリングの需要を加速させています。治療薬モニタリングは、投与される薬剤の正確な投与量を確認するために、血流中の複数の薬剤を測定する検査です。これは通常、治療指数が狭い、つまり治療量と毒性量の差が比較的小さい特定の薬剤の安全性と有効性を最適化するために行われます。抗不整脈薬、抗生物質、抗てんかん薬、向精神薬はすべて、その有効性と安全性を保証するためにモニタリングが必要です。治療薬物モニタリングの目的は、副作用のリスクを最小限に抑えながら、患者が望ましい治療効果を得るために適切な量の薬物を投与されていることを確認することです。特定の間隔で血液中の薬物濃度を測定し、薬物濃度を目標範囲内に維持するために必要に応じて投薬量を調整することが含まれます。正確な投薬量と薬剤の治療効果に関する人々の意識の高まりは、様々な薬剤による副作用や患者の健康への悪影響の発生率の増加と相まって、今後数年間における世界の治療薬モニタリング市場の成長に有利な機会を創出すると期待されています。

臨床試験に伴う研究開発の成長

市場は、治療薬物モニタリング（TDM）に関連する研究開発プロジェクトに注目が集まっていることや、さまざまな治療分野で薬物モニタリング検査が広く使用されていることも影響しています。がん、神経疾患、HIV、自己免疫疾患、心臓疾患などの罹患率の上昇と同様に、多様な適応症における技術の使用を拡大するための研究開発努力と臨床研究の増加が、世界の治療薬モニタリング市場の成長を支えています。Journal of Clinical Neurology誌は2021年8月、世界で7,000万人以上が罹患しているてんかんは、認知症、脳卒中に次いで3番目に罹患率の高い神経疾患であると報告しました。WHOの推計によると、2021年現在、世界で5,500万人以上が認知症を患っています。毎年、1,000万人近い症例が新たに報告されることになります。認知症で最も多いアルツハイマー型認知症は、症例の60～70％に関与している可能性があります。したがって、予測期間中、これらの疾患のリスクが高まることが、治療薬モニタリング市場の拡大に拍車をかけると予測されます。

臓器移植における治療モニタリングの使用

固形臓器移植を受ける患者を管理するには、免疫抑制剤の治療薬物モニタリングを実施する必要があります。免疫抑制剤は、体による臓器拒絶反応を防ぐために移植患者に投与されます。臨床医は、副作用の可能性と治療効果の理想的なバランスをとるために、それぞれの患者に投与する免疫抑制剤を調整しなければならないです。患者の薬力学や薬物動態は様々であるため、免疫抑制剤治療のモニタリングでこの目標を達成するのは難しいかもしれないです。

精密投与

精密投薬は近年ますます注目を集めており、治療薬モニタリングはこのアプローチにおいて重要な役割を果たすと期待されています。精密投薬は、遺伝、年齢、体重、臓器機能、併用薬などの患者固有の特徴に基づいて、個々の患者に合わせた薬物投与量を調整することを含みます。治療薬モニタリングは、個別化された治療結果を達成するために薬剤投与を最適化するのに役立ち、それゆえ治療薬モニタリングの実践において、精密投与アプローチのさらなる採用につながります。このことは、予測期間における世界の治療薬モニタリング市場の成長に新たな展望をもたらすでしょう。

ヘルスケアIT産業の繁栄

先端技術の利用の増加とヘルスケアへのITの統合は、ヘルスケア業界に革命をもたらしました。ヘルスケアにおける人工知能（AI）とデータ分析の利用は増加傾向にあり、治療薬モニタリングも例外ではありません。AIアルゴリズムとデータ分析技術は、薬物濃度データ、患者特性、臨床転帰の大規模データセットの分析に使用することができ、パターンと動向を特定し、投与戦略を最適化し、治療薬モニタリングの実践を改善することで、世界の治療薬モニタリング市場の成長に有利な機会を創出します。

デジタルヘルス技術と遠隔医療は近年勢いを増しており、治療薬モニタリングもこれらのプラットフォームに統合されつつあります。スマートフォンアプリやウェアラブルデバイスのようなデジタルヘルスツールは、薬物濃度の遠隔モニタリングを可能にし、より便利でアクセスしやすい治療薬モニタリングサービスを可能にします。遠隔医療はまた、特にヘルスケアへのアクセスが制限される農村部や遠隔地において、治療薬モニタリングの結果に基づく遠隔診察や投与量の調整を容易にし、それゆえ世界の治療薬モニタリング市場の成長を支えています。

利用可能なカスタマイズ

TechSci Researchは、与えられた市場データを用いて、企業の特定のニーズに応じてカスタマイズを提供します。レポートでは以下のカスタマイズが可能です：

企業情報

  • 追加市場プレイヤー（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

  • 市場の定義
  • 市場の範囲
    • 対象市場
    • 調査対象年
    • 主要市場セグメンテーション

第2章 調査手法

  • 調査目的
  • ベースライン調査手法
  • 主要産業パートナー
  • 主要協会と二次情報源
  • 予測手法
  • データの三角測量と検証
  • 仮定と限界

第3章 エグゼクティブサマリー

  • 市場概要
  • 主要市場セグメンテーションの概要
  • 主要市場プレーヤーの概要
  • 主要地域/国の概要
  • 市場促進要因・課題・動向の概要

第4章 顧客の声

第5章 治療薬モニタリングの世界市場展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • 製品別
    • 技術別
    • 薬物クラス別
    • エンドユーザー別
    • 地域別
    • 企業別（2022）
  • 製品マップ
    • 製品別
    • 技術別
    • 薬剤クラス別
    • エンドユーザー別
    • 地域別

第6章 北米の治療薬モニタリング市場展望

  • 市場規模および予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 技術別
    • 薬物クラス別
    • エンドユーザー別
    • 国別
  • 北米国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の治療薬モニタリング市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 技術別
    • 薬物クラス別
    • エンドユーザー別
    • 国別
  • 欧州国別分析
    • フランス
    • 英国
    • イタリア
    • ドイツ
    • スペイン

第8章 アジア太平洋地域の治療薬モニタリング市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 技術別
    • 薬物クラス別
    • エンドユーザー別
    • 国別
  • アジア太平洋地域国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米の治療薬モニタリング市場展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • 製品別
    • 技術別
    • 薬物クラス別
    • エンドユーザー別
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの治療薬モニタリング市場の展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • 製品別
    • 技術別
    • 薬物クラス別
    • エンドユーザー別
    • 国別
  • MEA：国別分析
    • 南アフリカ
    • アラブ首長国連邦
    • サウジアラビア
    • トルコ
    • エジプト

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 製品上市
  • 合併・買収
  • 技術の進歩

第13章 世界の治療薬モニタリング市場SWOT分析

第14章 競合情勢

  • Roche AG
    • Business Overview
    • Product Offerings
    • Recent Developments
    • Financials（In Case of Listed Companies）
    • Key Personnel
    • SWOT Analysis
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Beckman Coulter, Inc.
  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • bioMerieux, Inc.
  • Alere, Inc.

第15章 戦略的提言

目次
Product Code: 5028

Global Therapeutic Drug Monitoring Market is projected to witness impressive growth during the forecast period. The worldwide healthcare industry's expansion is accelerating the demand for therapeutic medication monitoring. Therapeutic drug monitoring is a test that measures several medications in the bloodstream to verify the correct dosage of medication being given. This is typically done to optimize the safety and effectiveness of certain medications that have a narrow therapeutic index, meaning that the difference between a therapeutic dose and a toxic dose is relatively small. Anti-arrhythmic, antibiotic, anti-epileptic, and psychotropic medications all require monitoring to guarantee their effectiveness and safety. The goal of therapeutic drug monitoring is to ensure that a patient is receiving the right dose of medication to achieve the desired therapeutic effect while minimizing the risk of adverse effects. It involves measuring drug concentrations in the blood at specific intervals and adjusting the medication dosage as needed to maintain drug levels within the target range. The growing awareness among the population pertaining to accurate dosage, and therapeutic effects of drugs coupled with increased incidences of side-effects and adverse impacts on patient health due to different medications is expected to create lucrative opportunities for the growth of global therapeutic drug monitoring market in the next few years.

The rise in demand for hospitals and medical care institutions across the globe acts as one of the major factors driving the growth of therapeutic drug monitoring market. The growing inclination for precision medicine and the significance of therapeutic drug monitoring (TDM) in organ transplant procedures both speed up market expansion. The therapeutic drug monitoring market is also positively impacted by changes in the medical sector, rising awareness, technical advancements, and a surge in pharmaceutical company investment. Additionally, the market players would benefit from increased use in the treatment of autoimmune illnesses during the projected period 2024 to 2028.

Additionally, the growing use of therapeutic drug monitoring across biologics industry and in point of care testing is further expected to support the global therapeutic drug monitoring market growth in the next few years. Biologic drugs, which are large complex molecules used to treat various conditions such as cancer, autoimmune diseases, and inflammatory disorders, are becoming increasingly important in clinical practice. Therapeutic Drug Monitoring for biologics, such as monoclonal antibodies, may involve measuring drug concentrations and anti-drug antibody levels to optimize dosing, assess treatment response, and manage immunogenicity. Similarly, Point-of-care testing (POCT), which involves performing diagnostic tests near the patient rather than sending samples to a central laboratory, is gaining popularity in clinical practice. POCT for Therapeutic Drug Monitoring may allow for more rapid and convenient monitoring of drug concentrations, enabling quicker dose adjustments and improving patient care, especially in critical care settings or resource-limited environments.

Growing Research and Development Along with Clinical Trials

The market is also influenced by the increased attention being paid to research and development projects relating to therapeutic drug monitoring (TDM) and the widespread use of the drug monitoring test in different therapeutic sectors. Increasing R&D efforts and clinical studies to broaden the use of technology in diverse indications, as well as rising rates of cancer, neurological disorders, HIV, autoimmune, and cardiac ailments, are supporting the growth of global therapeutic drug monitoring market. The Journal of Clinical Neurology reported in August 2021 that epilepsy, which affects over 70 million people globally, is the third most prevalent neurological condition after dementia and stroke. More than 55 million people are living with dementia worldwide as of 2021, estimates the WHO. Every year, there would be close to 10 million new cases reported. The most prevalent form of dementia, Alzheimer's disease, may be a factor in 60-70% of cases. Therefore, it is predicted that over the course of the projection period, rising risks of these diseases is anticipated to fuel Therapeutic Drug Monitoring market expansion.

Use of Therapeutic Monitoring in Organ Transplant

Managing patients receiving solid-organ transplants requires conducting therapeutic drug monitoring for immunosuppressive medicines. Immunosuppressants are given to transplant recipients in order to prevent organ rejection by the body. Clinicians must tailor the immunosuppressant medication they give to each patient in order to strike the ideal balance between the likelihood of side effects and the efficacy of treatment. It can be tough to accomplish this goal with immunosuppressant therapy monitoring since patients have varied pharmacodynamics and pharmacokinetics.

Precision Dosing

Precision medicine has gained increasing attention in recent years, and Therapeutic Drug Monitoring is expected to play a significant role in this approach. Precision dosing involves tailoring drug dosages to individual patients based on their specific characteristics, such as genetics, age, weight, organ function, and concomitant medications. Therapeutic Drug Monitoring can help optimize drug dosing to achieve personalized therapeutic outcomes, and hence lead to more adoption of precision dosing approaches in Therapeutic Drug Monitoring practice. This, in turn, will open new prospects for the growth of global therapeutic drug monitoring market in the forecast period.

Flourishing Healthcare IT Industry

The increasing use of advanced technologies and integration of IT into healthcare has revolutionized the healthcare industry. The use of artificial intelligence (AI) and data analytics in healthcare is on the rise, and Therapeutic Drug Monitoring is no exception. AI algorithms and data analytics techniques can be used to analyze large datasets of drug concentration data, patient characteristics, and clinical outcomes to identify patterns and trends, optimize dosing strategies, and improve Therapeutic Drug Monitoring practices, thereby creating lucrative opportunities for the growth of global therapeutic drug monitoring market.

Digital health technologies and telemedicine have gained momentum in recent years, and Therapeutic Drug Monitoring is also being integrated into these platforms. Digital health tools, such as smartphone apps or wearable devices, can enable remote monitoring of drug concentrations, allowing for more convenient and accessible Therapeutic Drug Monitoring services. Telemedicine can also facilitate remote consultations and dose adjustments based on Therapeutic Drug Monitoring results, particularly in rural or remote areas where access to healthcare may be limited, hence, supporting the growth of global therapeutic drug monitoring market.

Market Segmentation

Global Therapeutic Drug Monitoring Market is segmented based on product, technology, class of drug, end user, and region. By product, global therapeutic drug monitoring market can be segmented into consumables, equipment, immunoassay analyzers, chromatography & MS detectors, and clinical chemistry analyzers. By technology, global therapeutic drug monitoring market can be categorized into immunoassays and chromatography-mass spectrometry. Immunoassays can be further sub-segmented into Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, and Others. Chromatography-Mass Spectrometry can be split into LC-MS and GC-MS. By Class of Drug, global therapeutic drug monitoring market can be fragmented into Antiepileptic Drugs, Antibiotic Drug, Immunosuppressant Drugs, Antiarrhythmic Drug, Bronchodilator Drugs, Psychoactive Drugs, and Others. In terms of end users, global therapeutic drug monitoring market can be divided into Hospital Labs, Commercial & Private Lab, and Others. Regionally, global therapeutic drug monitoring market can be categorized into North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Recent Developments

  • In January 2021, Theradiag announced that it had received CE marking for four new i-Tracker test kits for biotherapy monitoring.
  • In November 2021, Boditech Med unveiled their brand-new all-in-one cartridge system and automated immunoassay analyzer with a blood collection tube at the MEDICA 2021 trade fair.
  • The Wyoming Board of Pharmacy and Bamboo Health, formerly Appriss Health and PatientPing, announced a partnership on June 29 in May 2022, to create a solution for the Wyoming Prescription Drug Monitoring Program (PDMP).
  • In January 2022, Seer launched a next-generation proteomics research platform that can be used for categorizing the tens of thousands of proteins within the human body that drive the biological functions of both life and disease.
  • In March 2022, Biognosys launched its expanded suite of proteomics platforms which provides its customers with deep biological insights across the entire R&D pipeline, from early-stage discovery to clinical settings.

Market players

Roche AG, Siemens Healthcare GmbH, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Abbott Laboratories, Inc., Agilent Technologies, Inc., bioMerieux, Inc., Alere, Inc, among others, are some of the key players operating in the global therapeutic drug monitoring market.

Report Scope:

In this report, the Global Therapeutic Drug Monitoring Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Global Therapeutic Drug Monitoring Market, By Product:

  • Consumables
  • Equipment
  • Immunoassay Analyzers
  • Chromatography & MS Detector
  • Clinical Chemistry Analyzers

Global Therapeutic Drug Monitoring Market, By Technology:

  • Immunoassay
    • Chemiluminescence Immunoassay
    • Colorimetric Immunoassay
    • Fluorescence
    • Immunoassay
    • Radioimmunoassay
    • Others
  • Chromatography-Mass Spectrometry
    • LC-MS
    • GC-MS

Global Therapeutic Drug Monitoring Market, By Class of Drug:

  • Antiepileptic Drug
  • Antibiotic Drug
  • Immunosuppressant Drug
  • Antiarrhythmic Drug
  • Bronchodilator Drug
  • Psychoactive Drug
  • Others

Global Therapeutic Drug Monitoring Market, By Class of Drug:

  • Hospital Labs
  • Commercial & Private Labs
  • Others

Global Therapeutic Drug Monitoring Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • UAE
    • South Arabia
    • Saudi Africa
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Therapeutic Drug Monitoring Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Therapeutic Drug Monitoring Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
    • 5.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
      • 5.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
      • 5.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
    • 5.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
    • 5.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2022)
  • 5.3. Product Map
    • 5.3.1. By Product
    • 5.3.2. By Technology
    • 5.3.3. By Class of Drug
    • 5.3.4. By End User
    • 5.3.5. By Region

6. North America Therapeutic Drug Monitoring Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
    • 6.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
      • 6.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
      • 6.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
    • 6.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
    • 6.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Therapeutic Drug Monitoring Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Class of Drug
        • 6.3.1.2.4. By End- User
    • 6.3.2. Canada Therapeutic Drug Monitoring Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Class of Drug
        • 6.3.2.2.4. By End- User
    • 6.3.3. Mexico Therapeutic Drug Monitoring Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Class of Drug
        • 6.3.3.2.4. By End- User

7. Europe Therapeutic Drug Monitoring Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
    • 7.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
      • 7.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
      • 7.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
    • 7.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
    • 7.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Therapeutic Drug Monitoring Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Class of Drug
        • 7.3.1.2.4. By End- User
    • 7.3.2. United Kingdom Therapeutic Drug Monitoring Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Class of Drug
        • 7.3.2.2.4. By End- User
    • 7.3.3. Italy Therapeutic Drug Monitoring Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Class of Drug
        • 7.3.3.2.4. By End- User
    • 7.3.4. Germany Therapeutic Drug Monitoring Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Class of Drug
        • 7.3.4.2.4. By End- User
    • 7.3.5. Spain Therapeutic Drug Monitoring Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Class of Drug
        • 7.3.5.2.4. By End- User

8. Asia-Pacific Therapeutic Drug Monitoring Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
    • 8.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
      • 8.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
      • 8.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
    • 8.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
    • 8.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Therapeutic Drug Monitoring Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Class of Drug
        • 8.3.1.2.4. By End- User
    • 8.3.2. India Therapeutic Drug Monitoring Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Class of Drug
        • 8.3.2.2.4. By End- User
    • 8.3.3. Japan Therapeutic Drug Monitoring Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Class of Drug
        • 8.3.3.2.4. By End- User
    • 8.3.4. South Korea Therapeutic Drug Monitoring Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Class of Drug
        • 8.3.4.2.4. By End- User
    • 8.3.5. Australia Therapeutic Drug Monitoring Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Class of Drug
        • 8.3.5.2.4. By End- User

9. South America Therapeutic Drug Monitoring Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
    • 9.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
      • 9.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
      • 9.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
    • 9.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
    • 9.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Therapeutic Drug Monitoring Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Class of Drug
        • 9.3.1.2.4. By End- User
    • 9.3.2. Argentina Therapeutic Drug Monitoring Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Class of Drug
        • 9.3.2.2.4. By End- User
    • 9.3.3. Colombia Therapeutic Drug Monitoring Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Class of Drug
        • 9.3.3.2.4. By End- User

10. Middle East and Africa Therapeutic Drug Monitoring Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography & MS Detectors, Clinical Chemistry Analyzers)
    • 10.2.2. By Technology (Immunoassays, Chromatography-Mass Spectrometry)
      • 10.2.2.1. By Immunoassays (Chemiluminescence Immunoassay, Colorimetric Immunoassay, Fluorescence, Immunoassay, Radioimmunoassay, Others)
      • 10.2.2.2. By Chromatography-Mass Spectrometry (LC-MS, GC-MS)
    • 10.2.3. By Class of Drug (Antiepileptic Drug, Antibiotic Drug, Immunosuppressant Drug, Antiarrhythmic Drug, Bronchodilator Drug, Psychoactive Drug, and Others)
    • 10.2.4. By End User (Hospital Labs, Commercial & Private Lab, Others)
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Therapeutic Drug Monitoring Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Class of Drug
        • 10.3.1.2.4. By End- User
    • 10.3.2. UAE Therapeutic Drug Monitoring Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Class of Drug
        • 10.3.2.2.4. By End- User
    • 10.3.3. Saudi Arabia Therapeutic Drug Monitoring Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Class of Drug
        • 10.3.3.2.4. By End- User
    • 10.3.4. Turkey Therapeutic Drug Monitoring Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product
        • 10.3.4.2.2. By Technology
        • 10.3.4.2.3. By Class of Drug
        • 10.3.4.2.4. By End- User
    • 10.3.5. Egypt Therapeutic Drug Monitoring Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Product
        • 10.3.5.2.2. By Technology
        • 10.3.5.2.3. By Class of Drug
        • 10.3.5.2.4. By End- User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Product Launches
  • 12.2. Mergers & Acquisitions
  • 12.3. Technological Advancements

13. Global Therapeutic Drug Monitoring Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Roche AG
    • 14.1.1. Business Overview
    • 14.1.2. Product Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (In Case of Listed Companies)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Siemens Healthcare GmbH
  • 14.3. Thermo Fisher Scientific, Inc.
  • 14.4. Bio-Rad Laboratories, Inc.
  • 14.5. Beckman Coulter, Inc.
  • 14.6. Abbott Laboratories, Inc.
  • 14.7. Agilent Technologies, Inc.
  • 14.8. bioMerieux, Inc.
  • 14.9. Alere, Inc.

15. Strategic Recommendations